In conclusion, HOXA11‐AS has found to be linked with tumor suppressor or oncogenic pathways of GC, whereas altered expression of HOXA11‐AS was linked with the incidence as well as the development of GC. The gene discussed is HOXA11; the disease is gastric cancer.